Table 1.
T
2-weighted imaging (T2-WI) |
Diffusion-weighted imaging (DWI) |
Dynamic contrast-enhanced (DCE) |
|
---|---|---|---|
Imaging planes | Same used for DWI and DCE | Same used for T2-WI and DCE | Same used for T2-WI and DWI |
Slice thickness | 3 mm, no gap | ≤4 mm, no gap | 3 mm, no gap |
Field of view | 12–20 cm a | 16–22 cm | 12–20 cm a |
In-plane dimension | ≤0.7 mm (phase) x ≤ 0.4 mm (frequency) | ≤2.5 mm (phase and frequency) | ≤2 mm (phase and frequency) |
Specific recommendations | |||
T2-WI acquisition | Axial plane: either straight axial to the patient or in an oblique axial plane matching the long axis of the prostate | - | - |
At least one additional orthogonal plane (sagittal and/or coronal) | - | - | |
3D axial as an adjunct to 2D acquisitions | - | - | |
Low b-value | - | 0 (preferably 50)–100 sec/mm2 | - |
Intermediate b-value | - | 800–1000 sec/mm2 | - |
High b-value | - |
|
- |
Temporal resolution | - | - | ≤15 s |
Total observation rate | - | - | >2 min |
Dose of GBCA | - | - | 0.1 mmol/kg |
Injection rate | - | - | 2 - 3cc/s |
Fat suppression/subtraction | - | - | Recommended |
Legend – T2-WI: T 2-weighted imaging; DWI: diffusion-weighted imaging; DCE: dynamic contrast enhanced; GBCA: Gadolinium-based contrast agent
to encompass the entire prostate gland and seminal vesicles